Recombinant Proteins From Plants

Chapter 1 From Neanderthal to Nanobiotech: From Plant Potions to Pharming with Plant Factories

Chapter 2 Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants.

Chapter 3 Transient expression of antibodies in plants using syringe agroinfiltration.

Chapter 4 Rapid system for evaluating bioproduction capacity of complex pharmaceutical proteins in plants.

Chapter 5 Production and localization of recombinant pharmaceuticals in transgenic seeds.

Chapter 6 Production of Antibody Fragments in Arabidopsis Seeds

Chapter 7 Production of plantibodies in Nicotiana plants.

Chapter 8 Physcomitrella patens: a non-vascular plant for recombinant protein production.

Chapter 9 Production of recombinant proteins in suspension-cultured plant cells.

Chapter 10 Chloroplast-derived vaccine antigens and biopharmaceuticals: protocols for expression, purification, or oral delivery and functional evaluation.

Chapter 11 Protein body induction: a new tool to produce and recover recombinant proteins in plants.

Chapter 12 A case study for plant-made pharmaceuticals comparing different plant expression and production systems.

Chapter 13 Glycosylation of antibody therapeutics: optimisation for purpose.

Chapter 14 N-glycosylation of plant recombinant pharmaceuticals.

Chapter 15 Companion protease inhibitors to protect recombinant proteins in transgenic plant extracts.

Chapter 16 Strategies for improving vaccine antigens expression in transgenic plants: fusion to carrier sequences.

Chapter 17 Immunomodulation of plant function by in vitro selected single-chain Fv intrabodies.

Chapter 18 On-chip detection of low-molecular-weight recombinant proteins in plant crude extracts by SELDI-TOF MS.

Chapter 19 Assessing the risk of undesirable immunogenicity/allergenicity of plant-derived therapeutic proteins.

Chapter 20 Biosafety, risk assessment and regulation of plant-made pharmaceuticals.